Literature DB >> 89512

Anticonvulsant drugs and cancer. A cohort study in patients with severe epilepsy.

S J White, A E McLean, C Howland.   

Abstract

Over 2000 epileptic patients admitted to the Chalfont Centre for Epilepsy between 1931 and 1971 and taking anticonvulsants were followed up to the end of 1977. Mortality between 1951 and 1977 was greatly in excess of that in the general population of England and Wales in that period allowing for age and sex. Some of the excess was directly attributable to epilepsy, but there were also more deaths from suicide and circulatory, respiratory, and malignant disease than would be expected. Apart from the brain and central nervous system, no particular site had a significant excess of tumours. In particular, there were no liver tumours (and only one gallbladder carcinoma). This makes it unlikely that the liver tumours produced on feeding phenobarbitone to mice are indicators of major human risk.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89512     DOI: 10.1016/s0140-6736(79)91505-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Hepatocellular adenoma associated with long-term exposure to phenobarbital: a paediatric case report.

Authors:  Caterina Cerminara; Valentina Bagnolo; Francesco De Leonardis; Antonella Coniglio; Denis Roberto; Eliana Compagnone; Paolo Curatolo
Journal:  Childs Nerv Syst       Date:  2011-11-29       Impact factor: 1.475

2.  Motor vehicle accidents, suicides, and assaults in epilepsy: a population-based study.

Authors:  C Kwon; M Liu; H Quan; V Thoo; S Wiebe; N Jetté
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

3.  Nonoccupational risk indicators of glioblastoma in adults.

Authors:  F Hochberg; P Toniolo; P Cole; M Salcman
Journal:  J Neurooncol       Date:  1990-02       Impact factor: 4.130

Review 4.  Environmental risk factors for primary malignant brain tumors: a review.

Authors:  M Wrensch; M L Bondy; J Wiencke; M Yost
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

5.  Epilepsy as a risk factor for cancer.

Authors:  C Adelöw; A Ahlbom; M Feychting; F Johnsson; J Schwartzbaum; T Tomson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06       Impact factor: 10.154

6.  Brain cancer and nonoccupational risk factors: a case-control study among workers at two nuclear facilities.

Authors:  A V Carpenter; W D Flanders; E L Frome; P Cole; S A Fry
Journal:  Am J Public Health       Date:  1987-09       Impact factor: 9.308

7.  Mortality in patients with epilepsy: a study of patients in long term residential care.

Authors:  P Klenerman; J W Sander; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

8.  The reversibility of phenytoin-induced IgA deficiency.

Authors:  N E Gilhus; J A Aarli
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

Review 9.  Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator.

Authors:  Clifford R Elcombe; Richard C Peffer; Douglas C Wolf; Jason Bailey; Remi Bars; David Bell; Russell C Cattley; Stephen S Ferguson; David Geter; Amber Goetz; Jay I Goodman; Susan Hester; Abigail Jacobs; Curtis J Omiecinski; Rita Schoeny; Wen Xie; Brian G Lake
Journal:  Crit Rev Toxicol       Date:  2013-11-04       Impact factor: 5.635

10.  Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200.

Authors:  Nandini Bhattacharjee; Surajit Pathak; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2007-06-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.